谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Final Results of the Double-Blind Placebo-Controlled Randomized Phase 2 LOTUS Trial of First-Line Ipatasertib Plus Paclitaxel for Inoperable Locally Advanced/metastatic Triple-Negative Breast Cancer

Duke-NUS Medical School,Oliveira Mafalda,Isakoff Steven J.,Im Seock-Ah,Espié Marc,Blau Sibel,Tan Antoinette R.,Saura Cristina,Wongchenko Matthew J.,Xu Na,Bradley Denise,Reilly Sarah-Jayne,Mani Aruna,Kim Sung-Bae

Breast cancer research and treatment（2021）

引用 15|浏览88
暂无评分
关键词
Ipatasertib,Oral,PI3K/AKT,Triple-negative breast cancer,First-line therapy
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要